ConductScience.org, home

Paper41545969

Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.

Ojala E and 6 others. BMC Cancer, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland. Papers, record 41545969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545969

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.
PubMed
Journal
BMC Cancer
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ojala EEmmy
2Kuitunen HHanne
3Rönkä AAino
4Pellonperä EEetu
5Selander TTuomas
6Puhakka IInka
7Kuittinen OOuti

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Nervous System NeoplasmsMajor topic
Educational StatusMajor topic
Lymphoma, Large B-Cell, DiffuseMajor topic
LymphomaMajor topic
Humans
Finland
Female
Incidence
Male
Middle Aged
Aged
Registries
Adult
Survival Rate
Aged, 80 and over
Young Adult
Adolescent

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129527660Impact of socioeconomic status on survival for patients with anal cancer.Cancer2018https://conductscience.org/library/papers/29527660PubMed
235347005The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity Score.Anticancer Res2022https://conductscience.org/library/papers/35347005PubMed
39486590Risk factors for primary central nervous system lymphoma: a case-control study.Cancer1998https://conductscience.org/library/papers/9486590PubMed
433499081Changing Incidence and Survival of Primary Central Nervous System Lymphoma in Australia: A 33-Year National Population-Based Study.Cancers (Basel)2021https://conductscience.org/library/papers/33499081PubMed
528450731Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015.Leukemia2017https://conductscience.org/library/papers/28450731PubMed
621915121Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.Br J Cancer2011https://conductscience.org/library/papers/21915121PubMed
736369792Socioeconomic inequality in cancer in the Nordic countries. A systematic review.Acta Oncol2022https://conductscience.org/library/papers/36369792PubMed
817084198Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.Surg Neurol2006https://conductscience.org/library/papers/17084198PubMed
940438704Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System-Outcomes in Finland: A Nationwide Population-Based Study.EJHaem2025https://conductscience.org/library/papers/40438704PubMed
1027018254Trends in primary central nervous system lymphoma incidence and survival in the U.S.Br J Haematol2016https://conductscience.org/library/papers/27018254PubMed
1129296804Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database.Blood Adv2016https://conductscience.org/library/papers/29296804PubMed
1217116938Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.J Clin Oncol2006https://conductscience.org/library/papers/17116938PubMed
1336091170Socioeconomic deprivation and survival outcomes in primary central nervous system lymphomas.Front Oncol2022https://conductscience.org/library/papers/36091170PubMed
1432552300Variation in cancer survival between hospital districts and within them in Finland.Acta Oncol2020https://conductscience.org/library/papers/32552300PubMed
1533573146Epidemiology of Non-Hodgkin's Lymphoma.Med Sci (Basel)2021https://conductscience.org/library/papers/33573146PubMed
1635241020Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis.BMC Cancer2022https://conductscience.org/library/papers/35241020PubMed
1728983970Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.Eur J Haematol2018https://conductscience.org/library/papers/28983970PubMed
1831377920Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.J Neurooncol2019https://conductscience.org/library/papers/31377920PubMed
1921145729Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database.Eur J Cancer2011https://conductscience.org/library/papers/21145729PubMed
2022315055Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study.Br J Cancer2012https://conductscience.org/library/papers/22315055PubMed

See all 40 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41545969

GET https://conductscience.org/api/papers/v1/41545969/references?page=2